GPR41 is expressed in intestinal Enteroendocrine Cells (EEC), stimulating the release of glucagon-like peptide-1 (GLP-1) and peptide YY (PYY). PYY can regulate intestinal movement, affecting the absorption of nutrients in the intestine, and GLP-1 can regulate satiety.
Propionate has been shown to induce satiety through induction of anorectic hormones (e.g., adipokine leptin) and intestinal gluconeogenesis (IGN), which also influences glucose metabolism
With respect to their use as an Energy source, propionate is primarily used by hepatocytes
Propionate alone inhibits resistin expression in the adipose tissue , and it is responsible for the blockage of Acetyl-CoA synthetase and therefore gluconeogenesis at the expense of cholesterol synthesis
Propionate has immunomodulatory capability
Propionate and butyrate also block the differentiation of bone marrow stem cells into dendritic cells (DCs ) via HDAC inhibition, thereby reducing undue inflammatory responses
Propionate blocks dendritic cell generation. They don't affect granulocytes. This depends on the transporter Sodium-Coupled Monocarboxylate Transporter 1 (SMCT1). It moves Propionate into cells. These metabolites inhibit histone deacetylases
Propionate might also have a role as modulators of glucose metabolism: absorption of propionate would result in lower glycaemic responses to oral glucose or standard meal - a response consistent with an ameliorated sensitivity to insulin
see also:
Biological effects / Functions & Short-Chain Fatty Acids (SCFAs)
Dendritic Cells (DCs) & Propanoate Metabolism / Propionate / Propionic acid
Glucagon Like Peptide 1 (GLP-1) & Propanoate Metabolism / Propionate / Propionic acid
Gluconeogenesis & Propanoate Metabolism / Propionate / Propionic acid
Glucose Uptake & Propanoate Metabolism / Propionate / Propionic acid
Histone Deacetylase (HDAC) Inhibition & Propanoate Metabolism / Propionate / Propionic acid
Propionate-producing bacteria